Brief: Odonate Therapeutics Announces Quarterly Loss Per Share Of $0.58
27/07/2021 16:21
July 27 (Reuters) - Odonate Therapeutics Inc ODT.O :
* ODONATE THERAPEUTICS ANNOUNCES FINANCIAL RESULTS FOR THE
THREE
AND SIX MONTHS ENDED JUNE 30, 2021
* QUARTERLY LOSS PER SHARE $0.58
* AS OF JUNE 30, 2021, HAD $110.1 MILLION IN CASH COMPARED
TO
$157.3 MILLION AS OF DECEMBER 31, 2020
Source text for Eikon: ID:nBw8CLSbSa
Further company coverage: ODT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Odonate
See all newsBrief: Odonate Announces Expected Delisting Of Its Stock
Brief: Odonate Therapeutics Announces Planned Return Of Capital To Stockholders Through Share Repurchase Plan
Brief: Odonate Therapeutics Announces Quarterly Loss Per Share Of $0.58
Odonate Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Odonate Therapeutics Inc expected to post a loss of 33 cents a share - Earnings Preview